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Abstract
Hundreds of genetic markers have shown associations with various complex diseases, yet the ‘‘missing heritability’’ remains
alarmingly elusive. Combinatorial interactions may account for a substantial portion of this missing heritability, but their
discoveries have been impeded by computational complexity and genetic heterogeneity. We present BlocBuster, a novel
systems-level approach that efficiently constructs genome-wide, allele-specific networks that accurately segregate
homogenous combinations of genetic factors, tests the associations of these combinations with the given phenotype, and
rigorously validates the results using a series of unbiased validation methods. BlocBuster employs a correlation measure
that is customized for single nucleotide polymorphisms and returns a multi-faceted collection of values that captures
genetic heterogeneity. We applied BlocBuster to analyze psoriasis, discovering a combinatorial pattern with an odds ratio of
3.64 and Bonferroni-corrected p-value of 5.01610216. This pattern was replicated in independent data, reflecting robustness
of the method. In addition to improving prediction of disease susceptibility and broadening our understanding of the
pathogenesis underlying psoriasis, these results demonstrate BlocBuster’s potential for discovering combinatorial genetic
associations within heterogeneous genome-wide data, thereby transcending the limiting ‘‘small effects’’ produced by
individual markers examined in isolation.
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in this region, as well as other regions of the genome, e.g., those
reported in [2,11–16]. Table 1 lists a collection of SNPs with odds
ratios of at least 1.4.
Overall, it is estimated that less than 20% of genetic heritability
can be accounted for by previous discoveries [4,17]. Furthermore,
many of these loci have not been replicated using independent
data, suggesting the existence of genetic heterogeneity in the
pathogenesis of this disease, as was implicated in the early work of
Burch and Rowell [18]. Furthermore, there are substantial
uncertainties about the precise contributing mutations that are
captured by linkage disequilibrium (LD) within each of the
associated genomic regions [2]. Importantly, previous research has
indicated that psoriasis arises due to the interactions of multiple
genetic factors [19]; thereby further complicating efforts to
understand this complex disease.
Identifying genetic risk factors and understanding the genetic
basis of complex diseases, such as psoriasis, are central goals of
medicine and biology. While GWAS have identified hundreds of
individual genetic markers associated with complex diseases, it is
clear that a substantial portion of heritability remains unexplained
for the vast majority of these enigmatic phenotypes [20]. The

Introduction
Psoriasis is an incurable complex disease that is characterized by
hyperproliferation and aberrant differentiation of the epidermis,
coupled with marked cutaneous inflammation. Environmental
triggers for onset of symptoms have been observed, yet genetic
predisposition is strong and heritability has been estimated at 80%
[1]. This disease appears with dramatic variations between
populations. It is essentially nonexistent in Eskimo and South
American Indian populations, affects 2%–3% of individuals with
European ancestry [2], and has been reported as high as 11.8% in
Kazach’ye, Russia [3].
The strongest known genetic risk factor for psoriasis, PSORS1,
is within the major histocompatibility complex (MHC) region on
chromosome 6 [4–7], a region that has been a primary focus of
psoriatic research spanning at least 40 years [5,8–10]. The area of
interest includes HLA-C, PSORS1C1 (aka SEEK1), PSORS1C2
(aka SPR1), PSORS1C3, CDSN, and several additional genes and
pseudogenes in a ,300-kb region of 6p21.3. A number of
genome-wide association studies (GWAS) focused on psoriasis
have identified associated single nucleotide polymorphisms (SNPs)
PLOS Computational Biology | www.ploscompbiol.org
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limit discoveries to these subset selections. On the other hand,
methods such as PLINK’s Fast Epistasis [31] and a statistic
introduced by Wu et al. [32,33] are computationally efficient and
can be used to blindly test all pairs of SNPs. However, these trials
impose hefty multiple testing corrections, resulting with little
progress in this area.
Alternatively, haplotypes have the potential to provide more
power than single SNPs [34–37]. A haplotype is a set of contiguous
allele-specific markers that ideally span a ‘‘haplotype block’’ in
which high LD is exhibited. Haplotype data are not directly
acquired for GWAS as current profiling methods provide
genotypes that specify the two alleles for a given SNP, but are
unable to align the alleles for each of the homologous chromosomes. Computational haplotype inference methods are commonly employed to phase genotypes into two homologous haplotypes,
each of which possesses a set of contiguous SNP alleles. However,
most computational approaches phase all SNPs supplied within
each region, which may result with the inclusion of un-informative
or even misleading markers.
The HLA-Cw6 haplotype family consisting of HLA-Cw0602—
Cw0613 alleles within PSORS1 has shown strong association with
psoriasis [5,19]. This haplotype is defined by the CCATCCG SNP
alleles at positions 213, 218, 341, 361, 387, 459, and 540 of
NM_002117.4 [5]. Nair et al. [5] completely sequenced the
PSORS1 region for one psoriatic individual and four controls,
genotyped risk alleles in 678 psoriatic families, and employed three
computational haplotype reconstruction methods as well as a
combinatorial analysis to implicate the HLA-Cw6 haplotype as the
most probable source of susceptibility within the PSORS1 locus
for early-onset psoriasis of individuals with European ancestry. It
should be noted that their analysis focused on age of onset and it
only included exons from known protein-coding genes. Noncoding regions were left unexamined.
It has been demonstrated that complex phenotypes, e.g. human
height [38], may be associated with markers that are not
necessarily in close proximity but rather even span across the
genome. Therefore, it is desirable to explore general combinations
of alleles without imposing restrictions regarding genomic
proximity. A number of approaches have been proposed for
identifying patterns of multiple markers that may be linked or
unlinked, yet interact to contribute to a phenotype of interest. For
example, Chen et al. [4] conducted combinatorial analyses of ten
SNPs that had been previously identified to each have individual
associations with psoriasis. These ten SNPs have been highly
replicated and included a SNP tagging HLA-Cw6. They tested risk
predictions via simple allele counts of multiple markers as well as
weighted combinations and observed that the contribution due to
the HLA-Cw6 SNP was about equal to the contribution of the
other nine SNPs combined. The authors noted the possibility of
overfitting in their weighted approach due to the use of the same
data for model construction and subsequent analysis [4]. More
generally, the limitation to SNPs with previously-identified
associations eradicates the possibility of identifying interacting
factors that exhibit negligible associations when examined in
isolation.
One approach to address this limitation is to consider all
genome-wide SNP states together for each individual and apply a
regression analysis or maximum likelihood estimate over the
genomic similarities between individuals. Yang et al. used this
approach to estimate variance in human height [39], a highly
heritable trait that is associated with hundreds of genetic variants
[40]. This type of approach is advantageous as it dramatically
reduces the burden of multiple testing corrections, with potential
to reduce false-negative signals. On the other hand, for many

Author Summary
Most complex diseases arise due to combinations of
genetic factors, yet current genome-wide association
studies (GWAS) typically examine individual genetic
markers in isolation because of the complexity of
considering a prohibitively large number of marker
combinations. Another complication for GWAS stems from
genetic heterogeneity, in which different subsets of
individuals develop a given disease due to different sets
of genetic factors. We present BlocBuster, a network-based
method that addresses these challenges and extracts intercorrelated genetic markers that manifest significant associations with complex diseases. Our analysis of psoriasis
GWAS data revealed a significant combinatorial genetic
pattern, which was validated using stringent computational tests and replication in independent data. This
pattern is more significant than other previously identified
markers. We also compared Pearson’s correlation coefficient and observed that it introduced more type I errors
and produced a less structured network than BlocBuster;
the former also broke the combinatorial pattern into
pieces. In addition to improving prediction of disease
susceptibility and broadening our understanding of the
pathogenesis underlying psoriasis, these results demonstrate BlocBuster’s effectiveness for discovering combinatorial genetic associations within heterogeneous backgrounds, thereby transcending the limiting ‘‘small effects’’
produced by individual markers examined in isolation.
susceptibility of complex diseases may be influenced by a
multiplicity of genetic factors, as well as environmental factors.
When considered individually, many contributing genetic factors
may have a small or undetectable effect on the disease, making
them difficult to identify [21,22]. Moreover, the effects of these risk
factors might not be simply additive; they may be compounded
epistatically through sophisticated interactions [23,24]. Standard
GWAS only identify single variants associated with the phenotype
of interest as they lack power to detect epistasis [25]. An additional
impediment to identification of combinatorial genetic interactions
is that the correction for multiple testing would be prohibitively
enormous as the number of tests grows exponentially in the
number of markers considered simultaneously [25]. In fact,
conducting such tests quickly becomes intractable. When the
number of markers is in the hundreds of thousands, or millions,
even just examining every pair of two markers can be computationally demanding. For example, one million markers can be
paired in 499,999,500,000 unique ways. The computational
challenge increases exponentially for higher-ordered combinations
– examining every combination of three markers requires
examining 1.761017 trios. Consequently, directly testing every
trio or higher-ordered combination is computationally intractable
using currently available resources and will likely remain infeasible
for the foreseeable future [26].
In order to examine pair-wise epistasis involving two SNPs,
several methods have been introduced in which subsets of SNPs
are selected using previously known biological information, and
pair-wise interactions are computed over these subsets [27–29].
For example, Strange et al. tested pair-wise interactions for a set of
SNPs that had each shown associations with psoriasis when tested
independently in standard GWAS, and discovered an interaction
between HLA-C and ERAP [30]. Chen et al. later tested ten SNPs
that had been indicted to be associated with psoriasis, but no
significant epistasis between pairs of SNPs was found [4]. Analyses
examining subsets of SNPs reduce the computational burden but
PLOS Computational Biology | www.ploscompbiol.org
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Table 1. Selection of previously identified risk alleles for psoriasis.

ID

Chr.

Position

Risk allele

Cases risk allele freq.

Controls risk allele freq.

OR

Closest gene

rs4406273

6

31266090

A

0.259

0.092

3.45

WASF5P

rs34536443

19

10463118

G

0.974

0.953

1.85

TYK2

rs2233278

5

150467189

C

0.090

0.058

1.61

TNIP1

rs9988642

1

67726104

T

0.952

0.929

1.52

IL23R

rs33980500

6

111913262

T

0.108

0.074

1.52

TRAF3IP2

rs12188300

5

158829527

T

0.132

0.095

1.45

IL12B

Shown are the SNP IDs, chromosome, position, risk allele frequencies [14], odds ratio (OR), and closest gene for all markers cited by Tsoi et al. [14] with an OR of at least
1.4. Positions follow Genome Build 37.3, as given by NCBI’s dbSNP website (http://www.ncbi.nlm.nih.gov/projects/SNP/).
doi:10.1371/journal.pcbi.1003766.t001

genetic data. Two commonly adopted correlation measures in the
biomedical domain are Pearson’s correlation coefficient (PCC)
[52] and the linkage disequilibrium measure, r2. Importantly, each
of these popular correlation methods returns a single scalar that
can be crippled by heterogeneity. In fact, all of the correlation
measures that we have examined, including PCC and r2, as well as
dot product and entropy, are global, in that individuals in the
entire group are viewed as a whole, and thus subtle but critical
subgroup structures, which manifest heterogeneity of the individuals in the group, are ignored. Figure 1 illustrates a simple
example for two SNPs, where half of the individuals are perfectly
correlated, while the other individuals are not correlated at all.
PCC and r2 have low values, due to penalization for the
uncorrelated individuals. In short, current correlation measures
treat the correlation for all of the individuals as a whole, and
consequently, fail to accommodate genetic heterogeneity within
the sample studied.
In order to address these pressing challenges, we present
BlocBuster, a systems-level, allele oriented network strategy
designed to generate viable biological hypotheses of epistatic
and/or additive interactions of genetic variations with a holistic
and unbiased approach that honors genetic heterogeneity.
BlocBuster has two key distinctions from the previous approaches.
First, we introduce a significant extension to the custom
correlation coefficient (CCC, ‘‘triple C’’) [53], a metric designed
to capture genetic heterogeneity by computing a multi-faceted
collection of correlation measurements. Each facet independently
captures a single homogeneous type of correlation. Second, we
build an unbiased network of SNP alleles, identify clusters of
correlated alleles within the network, test each entire cluster for
phenotypic association, and rigorously validate the results. During
network construction, we consider all individuals together, without
phenotype labeling, and consider all markers simultaneously,
thereby assessing relationships in toto. In our current implementation, each bi-allelic SNP is represented by two nodes, one for
each SNP allele, which can be readily extended to multi-allelic
SNPs. CCC is computed for every pair of SNPs, thereby revealing
correlations that arise regardless of genomic distances between the
SNPs. Significant values within the CCC vectors are represented
by edges between the nodes representing the correlated alleles.
After the network is built, we retrieve clusters of inter-correlated
nodes that arise naturally separated from each other and do not
require partitioning. Each of the corresponding patterns of SNP
alleles is then tested for variation between phenotypic groups.
Consequently, BlocBuster extracts patterns of inter-correlated
haploid markers, referred to as blocs. These blocs seamlessly
capture genetic heterogeneity as they are built upon the multifaceted CCC metric that treats each pair of SNP alleles

complex traits the number of causal loci associated with a
phenotype of interest may account for a small or negligible
proportion of variation between individuals. For example, two
individuals might exhibit high genomic similarity due to shared
ancestry dominating the similarity measure; while another two
individuals with less common ancestry, yet sharing a handful of
causal alleles contributing to a given phenotype, might exhibit low
genomic similarity. This problem can be exacerbated by genetic
heterogeneity, as described below. In short, the abstraction of
many hundreds of thousands of variable markers into a similarity
measure that captures a small handful of markers associated with a
particular phenotype could be expected to require extremely large
sample size or the use of previously known information.
Several network construction approaches utilizing known
information have been introduced to capture combinations of
markers with phenotypic associations, such as nested clade analysis
[41], treescanning [42], simulated evaporative cooling networks
[43], SNPrank [44], Hua et al.’s SNP-SNP networks [28],
statistical epistasis networks [45], and Li et al.’s two-step method
[27]. These methods utilize phenotypic information and/or
biological knowledge in construction of networks that are
subsequently explored. Networks that have strong community
structure can be partitioned into clusters, or communities, of nodes
such that there is a high density of edges within each community
and few edges spanning between communities. Many approaches
utilize clustering methods to partition the network, followed by the
use of reference databases – e.g. Gene Ontology [46], KEGG [47],
DAVID [48], or MetaCore – to evaluate gene enrichment for each
community. Due to the assumptions and/or biases that are
introduced during network construction, it is difficult to accurately
evaluate the contributions using enrichment analyses based upon
reference databases.
In addition to the challenges of combinatorial interactions,
another serious issue that is impeding identification of phenotypic
associations in GWAS is that most complex diseases are subject to
genetic heterogeneity, in which different groups of individuals
develop the same disease due to different genetic factors or geneby-environment interactions. Heterogeneity can manifest as
different mutations within a single gene or as mutations within
different genes. For example, cystic fibrosis can arise due to more
than 1,000 different mutations within a single gene, CFTR [49],
and retinitis pigmentosa can arise due to specific mutations in any
one of at least 45 different genes [50]. The inability to replicate
psoriatic associations in populations that are distinct from the
original population may be due to heterogeneity [51]. Critically,
heterogeneity has not been adequately quantified nor even
captured by the currently available measures of correlation, which
is one of the most fundamental concepts in statistical analyses of
PLOS Computational Biology | www.ploscompbiol.org
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subsequently tests these blocs for phenotypic associations. Briefly,
an allele-specific network is constructed in which each SNP allele
is represented by a node and edges are placed between pairs of
nodes representing SNP alleles that exhibit significant pair-wise
correlations. In order to address genetic heterogeneity, we utilize a
multi-faceted correlation metric that is customized for SNP data,
referred to as CCC. Note that the CCC computation is conducted
for the entire sample of all individuals and the network
construction is blind to phenotype status. Furthermore, CCC is
computed for every pair of SNPs, providing a holistic systems-level
network. After the network is constructed, groups of nodes that are
connected by edges are easily identified as they are completely
isolated from each other. Then the entire pattern of SNP alleles
represented by each bloc is tested as a whole for association with
the phenotype. These patterns are comprised of specific SNP
alleles and can be considered as a type of haplotype – with two
noteworthy exceptions: (1) only SNP alleles that exhibit intercorrelations are included and (2) the SNPs are not necessarily
contiguous and are included regardless of genomic position.
In this section, we present the results provided by BlocBuster for
psoriasis GWAS data. These results were carefully validated using
a series of computational trials and these outcomes are overviewed. The most significant result is a bloc of 17 SNP alleles that
is strongly associated with psoriasis. We replicated this result by
utilizing independent data and found that the bloc has a stronger
association in the replication data than in the discovery data.
Finally, we compare CCC with a standard correlation metric,
Pearson’s correlation coefficient (PCC), and observe the benefits of
utilizing a metric that is customized specifically for SNP data and
is designed to accommodate heterogeneity.

Figure 1. Genotypes for ten individuals for a pair of SNPs. The
first five individuals are perfectly correlated, but the others are not
correlated at all. The absolute value of PCC is 0.3 and r2 returns 0.0, due
to the uncorrelated individuals. CCC supplies four correlation values,
each of which corresponds to a specific type of correlation. These
values are low for three of the possible combinations, but a high value
of 0.7 for the T-G combination was returned.
doi:10.1371/journal.pcbi.1003766.g001

independently, thereby avoiding reduction of the correlation value
by subgroups of individuals that lack correlation for the pair of
alleles. An allele-specific network is utilized to eliminate the
merging of both SNP allele states into a single node, which can
lead to false positive signals, as described below. Our approach is
direct and efficient, and scales efficiently to millions of markers
with reasonable computational resources.
In order to ensure accuracy of results, BlocBuster employs a
series of computational validation trials, including two types of
permutation tests, bootstrapping trials, variations of network
density, and visual inspection. These computations economically
screen the results and can be utilized prior to investment in
replication trials using independent data.
Aiming at identification of combinatorial interactions of SNP
alleles underlying pathogenesis of psoriasis, we applied BlocBuster
to genome-wide data for psoriatic cases and normal controls. This
analysis identified a bloc of SNP alleles that is significantly
associated with psoriasis and improves upon previous results by
supplying a precise allelic pattern within the major histocompatibility complex (MHC). This newly identified genetic pattern was
rigorously validated using multiple computational screening tests
and was subsequently replicated in independent data, thereby
ensuring its accuracy and suitability for further research efforts.
Finally, we compare and contrast our approach with Pearson’s
Correlation Coefficient (PCC) and observe that the PCC network
had substantially weaker community structure, was more likely to
introduce false-positive correlations, and required three times as
much computation time.

Network analysis of psoriasis
We used both psoriatic cases and normal controls in the GAIN
General Research Use (GRU) genome-wide data to construct the
BlocBuster network for this complex disease. These data consisted
of 443,020 autosomal SNPs for 929 cases and 681 controls (see
Methods). The correlation between every pair of SNPs was
computed using CCC. We set the number of edges in the network
equal to the number of SNPs, consequently selecting edges with
the highest 443,020 CCC values – see Methods for discussion of
this parameter selection and validation trial results for significance
of this threshold and sensitivity of its value. The network was
comprised of 886,040 nodes as each SNP allele was represented by
a node. Consequently, the average degree of each node in the
network was one. If the edges were uniformly distributed, the
network would consist of 443,020 doubletons, each of which was
comprised of a single edge connecting two nodes; with every node
connected to precisely one other node in the network.
In sharp contrast to a network with uniform distribution, the
observed network exhibited strong community structure. Instead
of doubletons spread across the network, there were a large
percentage of singleton nodes with no incident edges, and many
discrete blocs of densely connected nodes, with each bloc isolated
from one another. Specifically, 631,462 (71.3%) of the nodes were
singletons, and there were 54,425 discrete blocs, ranging from 2 to
313 nodes, with an average of 4.7 nodes per bloc.
Importantly, the blocs arose naturally separated in the network
and there was no need to employ methods such as clustering
strategies to partition the nodes. For each of the 54,425 blocs, the
frequencies of the entire corresponding SNP allele pattern were
tallied and the odds ratio with 95% confidence interval (CI) and
Bonferroni-corrected p-value, based on the G-test of independence, were computed between cases and controls (see Methods).
Any individual that was missing more than 5% of the genotypes in

Results
In order to discover combinatorial interactions in heterogeneous
samples of a given complex disease, we developed a novel
computational approach, referred to as BlocBuster, which
identifies clusters, or blocs, of correlated SNP alleles and
PLOS Computational Biology | www.ploscompbiol.org
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the bloc was not included in these calculations. Note that other
than these missing genotypes, the entire SNP allele pattern must be
present to be counted in the bloc frequency. This policy assumes
that the entire pattern is required for the phenotypic association
for a given subset of individuals. However, it is possible that one or
more of the SNP alleles in the bloc is not essential. The visual
validation described below facilitates the observation of this
situation, should it arise.
This analysis revealed a single bloc, referred to as ps_1, which
was comprised of 17 SNP alleles and had a significant odds ratio
and CI (Figure 2). Individuals missing more than 5% data for
these 17 SNPs were omitted, leaving sample sizes of 785 cases and
585 controls. This pattern had a ‘‘protective’’ association with
frequencies of 0.179 and 0.265 for the psoriatic cases and controls,
respectively, with an odds ratio of 0.605 (CI: 0.482–0.759).
However, the p-value was not significant after Bonferroni
correction. On the other hand, the alternate alleles for all 17
SNPs comprised a risk pattern that had frequencies of 0.220 and
0.072 for cases and controls, respectively. This risk pattern had an
odds ratio of 3.64 (CI: 2.75–4.80) and Bonferroni-corrected pvalue of 5.01610216. The risk pattern is more significant than the
protective pattern when comparing cases to controls. However,
when considering all individuals together, the protective pattern is
more pronounced (with a frequency of 0.216) than the risk pattern
(with a frequency of 0.157), which is likely the reason that the
protective pattern appeared in the network that was constructed
using all individuals without phenotypic labeling.
Table 2 lists the 17 nodes in ps_1, along with alleles and their
individual frequencies. The SNPs within ps_1 span ,211 kb, from
positions 31054511 to 31265057 in the MHC on chromosome 6.
Two SNPs are located within known genes: rs3130573 in
PSORS1C1 (aka SEEK1) and PSORS1C2 (aka SPR1), and
rs1265078 in CCHCR1 (coiled-coil a-helical rod protein 1, aka
HCR). All three of these genes have been previously associated
with psoriasis [54,55].

Figure 2. Plot of 17-node bloc, ps_1. Each node represents a SNP
allele and each edge represents a significant correlation between the
SNP alleles representing its endpoints. The pattern corresponding to
this bloc exhibited a risk association with psoriasis, with an odds ratio of
3.64 (CI: 2.75–4.80) and Bonferroni-corrected p-value of 5.01610216 in
the discovery data and odds ratio of 3.86 (CI: 2.98–5.01) and Bonferronicorrected p-value of 1.81610225 in the validation data.
doi:10.1371/journal.pcbi.1003766.g002

0.6515. The lowest CCC value representing an edge in the
original network was 0.6949. This result indicates that it is not
likely that there were any edges representing false-positive
correlations in the original network.
In the third validation trial, we varied the density of the network
to test the sensitivity to this parameter. For a given number of
edges n, the highest n CCC values were determined and the
corresponding SNP allele pairs were connected by edges in the
network. We constructed networks with 50,000 to 500,000 edges,
in increments of 50,000, and tracked ps_1 within these networks.
The CCC thresholds for edge placement for these trials varied
from 0.7501 (for 50,000 edges) to 0.6906 (for 500,000 edges),
which is substantially higher than the maximum CCC value of
0.6515 that was produced during the permutation trials, indicating
that it is not likely that false positives arose during these trials.
The sparse networks with no more than 300,000 edges did not
include ps_1. The 350,000 edge network possessed a bloc with 16
of the 17 nodes in ps_1; node 6 was not included in this bloc. The
association of this bloc was similar to the original 17-node bloc as it
had frequencies of 0.218 and 0.071 for cases and controls,
respectively, with an odds ratio of 3.64 (CI: 2.83–4.67) and
Bonferroni corrected p-value of 1.81610223. The 400,000 edge
network possessed the entire 17-node bloc. The 450,000 edge
network added another node to the bloc, rs2442736. This bloc had
frequencies of 0.137 and 0.039 for the cases and controls,
respectively, with an odds ratio of 3.91 (CI: 2.81–5.45) and
Bonferroni-corrected p-value of 1.10610214. For the 500,000
edge network, the bloc grew to 30 nodes, had frequencies of 0.020
and 0.006, and an odds ratio of 3.32 (CI:1.54–7.19). The p-value
was not significant after correcting for multiple testing. Table S1
lists these 30 SNP alleles. Overall, ps_1 was significant for a range
of network densities. However, when the network grew to a half
million edges, this bloc grew substantially, its frequency fell to less
than two percent, and it exhibited a weaker association with the
phenotype.

Computational validations
In order to evaluate the robustness of our results, we ran five
computational validations: two types of permutation tests, trials in
which we varied the network density, bootstrapping trials, plus
visualization of results. The first series of permutation tests were
conducted to determine a significant G-test score given multiple
tests (see Methods). In these trials, the phenotypic labels of
individuals were permuted prior to computing G-test scores for
each of the 54,425 blocs. Each permutation trial destroys the
associations between genotypes and the phenotype, but maintains
the statistical properties of the whole so that they can be used as
background for this significance analysis. These trials indicated a
G-test score of 23.7 corresponds to a corrected p-value of 0.05. A
G-test score of 24.1 corresponds to the same significance when
using Bonferroni correction, indicating these two approaches for
multiple testing corrections are similar for this study.
The second series of permutation tests were used to remove
inherent correlations among SNP alleles in the data in order to
verify that it is unlikely that type I errors were introduced during
computations of correlations. For each SNP, we randomly shuffled
the genotypes across all individuals. This randomization breaks
inherent correlations while each SNP retains the same allele
frequencies and balance of genotype states as in the original data.
Consequently, it is not expected that there would be significant
correlations within the permuted data. These trials aim to estimate
the highest CCC value that might arise by random chance for
uncorrelated data drawn from these samples. The maximum CCC
value for 9.861010 pairs of SNPs with permuted genotypes was
PLOS Computational Biology | www.ploscompbiol.org
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Table 2. Description of SNP alleles corresponding to the nodes in ps_1.

Node #

Risk Allele

Freq. Cases

Freq. Controls

OR

rsID

Chr. Position

1

G

0.431

0.324

1.58

rs3130573

31106268

2

C

0.421

0.300

1.70

rs1265078

31112602

3

T

0.394

0.266

1.79

rs3130467

31187075

4

C

0.391

0.260

1.83

rs3130517

31190303

5

T

0.381

0.252

1.83

rs3130713

31205617

6

T

0.530

0.438

1.45

rs3130685

31206206

7

C

0.360

0.233

1.85

rs2394895

31206979

8

A

0.469

0.346

1.67

rs3130955

31054511

9

A

0.516

0.413

1.52

rs9263967

31186245

10

T

0.404

0.256

1.97

rs2844627

31229462

11

T

0.298

0.150

2.41

rs12191877

31252925

12

C

0.513

0.401

1.57

rs2524163

31259579

13

A

0.513

0.405

1.55

rs2243868

31261276

14

C

0.341

0.208

1.97

rs2894207

31263751

15

A

0.296

0.154

2.31

rs9468933

31265057

16

G

0.424

0.288

1.82

rs7773175

31240959

17

A

0.404

0.291

1.65

rs9380237

31264392

All SNPs are located on chromosome 6. The node numbers correspond to the numbers in Figures 2 and 4. Shown are the frequencies of the risk alleles for psoriatic
cases and controls, odds ratio (OR) for each individual SNP, SNP IDs, and chromosomal positions, where rsID is the dbSNP assigned reference SNP identification number
and positions are for Genome Build 37.3, as given by NCBI’s dbSNP website (http://www.ncbi.nlm.nih.gov/projects/SNP/).
doi:10.1371/journal.pcbi.1003766.t002

In our fourth validation, we tested the sensitivity of the selection of
individuals with a series of bootstrapping trials. This resampling
technique evaluates the stability of results computed over a sample
drawn from a population and has been shown to be more accurate
than methods that are based on asymptotic approximation or
normality assumptions [56]. We conducted 1,000 bootstrapping trials
in which we randomly selected half of the cases and half of the
controls and computed the odds ratios and 95% confidence interval
for ps_1. Over the 1,000 computations, the odds ratios had a mean of
3.66 with CI: 3.64–3.69. This result is slightly better than the results
found for the entire dataset, and the confidence interval is tighter, as it
was based on 1,000 trials. The average p-value was 2.91610211,
which is larger than the original result, likely due to the fact that these
trials each had half of the original sample size. Overall, these results
indicate robustness to sample selection as randomly selected subsets of
the individuals yield strong phenotypic associations.
Finally, we extracted the genotypes for the SNPs corresponding
to ps_1, and plotted them for visual inspection, as shown in
Figure 3. These plots illustrate the variation of the genotypes
across psoriatic cases and controls.

time than CCC or PCC, and is not practical for studies involving
large numbers of SNPs. Accordingly, in this section we disregard
r2 and focus on comparisons between PCC with CCC. Due to
computational demands, we used the 30,178 SNPs from
chromosome 6 for the following trials. We first computed all
pair-wise correlations using both metrics and compared the
network structures that each produced. Second, we ran permutation trials and compared the numbers of false positives produced
by each method, as well as average computation time. Third, we
extracted the clusters in the PCC network that possessed the SNPs
in ps_1 and compared differences in the results.
First, we created two networks for the SNPs using each of the
correlation metrics. BlocBuster networks possess two nodes for
each SNP thereby capturing allele-specific correlations. In
comparison, PCC does not return the alleles associated with a
correlation, so only one node was used to specify each SNP. In
order to compare the two methods, we built a CCC network with
only one node per SNP and placed an edge between a SNP pair if
any of the four allele-specific CCC facets exceeded the threshold.
Setting the number of edges equal to the number of SNPs for
chromosome 6 corresponded to thresholds of 0.6990 and 0.7350
for CCC and PCC, respectively.
These two networks were compared for community structure.
Strong community structure in a network opposes uniform edge
distribution and is instead exemplified by clusters of tightly
interconnected nodes such that few edges connect these clusters
[57]. Overall, the CCC network had substantially stronger
community structure than the PCC network as the edges in the
latter were more dispersed throughout the network, as summarized in Table 3. In particular, the CCC network had only 934
doubletons while the PCC network possessed 2,550 of these
dispersed edges. Furthermore, the CCC network possessed
substantially higher percentages of nodes that were singletons
than the PCC network (49.73% vs. 29.25%). Consequently, all of

Replication in independent data
We tested the identified bloc ps_1 using the GAIN Autoimmune
Disease Only (ADO) data. These data consisted of 443,020 genotype
states for 439 psoriatic cases and 728 controls. For these data, the
frequencies of the entire ps_1 bloc were 0.260 and 0.083, with an odds
ratio of 3.86 (CI: 2.98–5.01) and p-value of 1.81610225. Note that only
one bloc was tested, so there was no correction for multiple testing.
These results are even stronger than those for the discovery data,
demonstrating the validity of the association of this bloc with psoriasis.

Comparison between CCC and PCC
In our analysis, we found that the linkage disequilibrium
measure, r2, required many thousands times more computation
PLOS Computational Biology | www.ploscompbiol.org
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Figure 3. Genotype states of (a) 929 psoriatic cases and (b) 681
controls for bloc ps_1. (Best viewed in color.) Each row represents an
individual and each column represents a SNP. Dark blue represents a
homozygote for the protective allele, light blue represents a
heterozygote, red represents a homozygote for the risk allele, and
white indicates missing data. Individuals (rows) were rearranged using
TSP+k [77] in order to place similar individuals near each other and
enhance visualization of patterns.
doi:10.1371/journal.pcbi.1003766.g003

the edges in the CCC network were concentrated over about half
of the network nodes, while the PCC edges were spread over about
70% of the nodes. Finally, the largest cluster in the CCC network
contained 290 nodes with 2,400 edges, while the largest in the
PCC network was comprised of 410 nodes and 2,402 edges. These
clusters possessed almost exactly the same number of edges, yet the
PCC cluster was comprised of substantially more nodes and was
notably less dense. Overall, despite the fact that the networks
possessed the same numbers of nodes and edges, the edges were
more highly concentrated into fewer clusters in the CCC network
and more dispersed in the PCC network.
In our second comparison we ran ten permutation trials in
which genotypes were randomly reordered over the individuals as
previously described, computing CCC and PCC on each of the
permuted datasets. The maximum PCC value for the entire
networks ranged from 0.7068 to 1.0000 over the ten trials, with an
average of 0.8534. Despite the fact that true correlations should
have been eliminated from the data, there were a total of seven
edges with PCC values of 1.0000. The maximum CCC values
ranged from 0.6474 to 0.6492, with an average of 0.6483. These
results suggest that CCC is less likely than PCC to produce
spurious edges. It also indicates that the original PCC network
might have possessed false positive edges as the threshold was
0.7350, while it is unlikely that the original CCC network
possessed false positive edges with its threshold of 0.6990.
These trials also provided an opportunity to compare average
computation time requirements. The CCC trials averaged
135 minutes and PCC averaged 402 minutes per trial; the former
was three times faster than the latter.
Finally, the clusters in the PCC network possessing the SNPs in
bloc ps_1 were examined. Twelve of the 17 SNPs in ps_1
comprised one cluster in the PCC network, two additional SNPs
were connected together as a doubleton, and the other three were
singletons, as shown in Figure 4. As shown in the figure, there
were only 19 significant PCC correlations amongst these 17 SNPs,
whereas there were 39 significant CCC correlations. This result
demonstrates an example in which CCC identified a larger pattern
with strong inter-correlations than those identified using PCC.

Discussion
Psoriasis is a common complex disease that has been extensively
studied and several GWAS have been previously conducted [2,11–
16]. Individual SNPs associated with psoriasis [14] with odds ratios
as high as 3.45 have been identified (Table 1). By employing an
unbiased, allele-specific network approach, BlocBuster identified a
bloc, ps_1, consisting of a combination of 17 SNP alleles that are
highly inter-correlated and exhibit a psoriatic risk association as a
whole with an odds ratio of 3.64 (CI: 2.75–4.80) and Bonferronicorrected p-value of 5.01610216 in the discovery data. This bloc
had an odds ratio of 3.86 (CI: 2.98–5.01) and p-value of
1.81610225 in the validation data. BlocBuster’s success in
replicating a 17-SNP allele pattern in independent data reflects
the robustness of the approach. In the network, each edge within
the bloc represents a strong allele-specific correlation that is not
PLOS Computational Biology | www.ploscompbiol.org
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Table 3. Comparisons between PCC and CCC.

% of Nodes that were Singletons

# of Doubletons

Average Cluster Size

Largest Cluster (# of nodes/# of edges)

PCC

CCC

PCC

CCC

PCC

CCC

PCC

CCC

29.25%

49.73%

2,550

934

3.89

5.38

410/2,402

290/2,400

Networks were constructed for chromosome 6 using PCC and CCC to determine edge placements. The number of nodes and number of edges were the same for the
PCC and CCC networks. Shown are the percentages of nodes that were singletons (nodes with no adjacent edges), number of doubletons (two nodes connected by an
edge and isolated from other nodes), average number of nodes per cluster, and the number of nodes and edges in the largest cluster. Overall, the CCC network
exhibited stronger community structure than the PCC network.
doi:10.1371/journal.pcbi.1003766.t003

weakened by genetic heterogeneity. As shown in Figure 2, the 17
SNP alleles are densely interconnected with high pairwise CCC
correlations, while none exhibit such correlations for any other
SNP allele outside the bloc. The use of a multi-faceted correlation
metric and the retention of allele-specific information in network
construction are key factors in BlocBuster’s replication success.
Node 1 of ps_1 corresponds to SNP rs3130573, which is in the
overlapping region of the PSORS1C1 (aka SEEK1) and
PSORS1C2 (aka SPR1) genes. Both of these genes have been
previously indicted to be associated with psoriasis [54]. Node 2
corresponds to rs1265078 in CCHCR1 (coiled-coil a-helical rod
protein 1, aka HCR). CCHCR1 has been observed to have
differential expression in psoriatic lesions when compared with
either normal skin or eczema lesions [55]. It has been suggested
that this gene is involved in the regulation of keratinocyte
proliferation and may play a central role in the progression of
psoriatic lesions [55]. The other SNPs in ps_1 lie in intergenic
regions as shown in Figure 5. Node 16 corresponds to rs7773175,
which is upstream from HLA-C, a gene that has been associated
with psoriasis over decades of research efforts [5,15,30,58–60].
Node 11, rs12191877, was previously identified in a psoriasis
GWAS conducted by Nair et al. [16]. In general, some of these
SNP alleles might be directly involved in protein or regulatory
variations underlying the pathogenesis of psoriasis and some might
only hitch-hike along with causal variants. Further research is
needed to discern these roles. Importantly, the results presented
provide a highly defined pattern of SNP alleles to support such
research.
The 17 SNPs in ps_1 span a 211 kb region of chromosome 6, as
shown in Figure 5. This region is within the Major Histocompatibility Complex (MHC) [61]. The MHC is a distinctive region of
the genome and plays a fundamental role in human immune
function. It has exceptionally high polymorphism [62] and
possesses the greatest gene density in the genome [61]. Many
MHC genes encode cell-surface antigens that mediate leukocyte
interactions and they are associated with more than 100 human
diseases, including common diseases such as diabetes, asthma,
rheumatoid arthritis, as well as psoriasis, yielding strong selective
pressures [63]. On the other hand, this region displays a
heterozygote advantage by producing an enhanced immunocompetence; and diversity of these genes also increases fitness at the
population level [64]. Several studies suggest there exist olfactionmediated mate selection for increasing this diversity [65–70].
There exist hundreds of different alleles for the MHC genes [71]
and each allele might appear on several different haplotype
backgrounds as they may have arisen in various cycles of
frequency fluctuations that arose during the balancing selection
acting upon these genes throughout human history [62]. Indeed,
the associated bloc lies within an exceptionally diverse genomic
region and the occurrence of 17 SNP alleles in a single pattern
PLOS Computational Biology | www.ploscompbiol.org

with strong psoriatic association provides precise information for
focusing future investigations.
Our network-based result is advantageous over the results from
conventional GWAS. As shown in Table 2, the highest odds ratio
for any single SNP in ps_1 is 2.41 (SNP rs12191877). In contrast,
the entire bloc as one unit exhibited odds ratios of 3.64 and 3.86
for the discovery and validation data, respectively. These results
illuminate the discriminative power of combinatorial patterns and
the capability of this approach for transcending single-marker
methods. While the cardinality of the actual causal mutations
which are tagged by the SNPs in ps_1 may be less than 17 due to
LD, recognition of multiple SNP alleles may reveal combinatorial
interconnection among these SNPs underlying the etiology of
psoriasis and tightens the fingerprint of the causal mutations,
providing a fine-scaled pattern for future explorations of underlying genetic factors.
BlocBuster utilizes stringent validation procedures to efficiently
weed out uninformative results to reduce resources that may have
otherwise ensued in follow-up studies. These validation trials

Figure 4. Plot of PCC edges for the 17 SNPs in the ps_1 bloc.
BlocBuster connected these 17 nodes into a single connected
component, while PCC separated them into disconnected components.
Overall, PCC identified 19 pair-wise correlations and CCC identified 39
correlations amongst these SNPs, as represented by edges in this plot
and Figure 2.
doi:10.1371/journal.pcbi.1003766.g004
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scrutinize blocs identified within the discovery data by examining
their properties; specifically the robustness of the pattern and the
improbability that it possesses type I errors or captures an
incomplete and misleading portion of the data.
The permutation tests in which genotypes were randomly
reordered indicated that it is highly unlikely an edge in the
BlocBuster network appeared by random chance. On the other
hand, PCC produced spurious edges and was not as capable to
discern true correlations from noise, presumably due to its
inherent inability of capturing genetic heterogeneity. Consequently, seven edges with PCC values of 1.0000 were computed from
the permuted data in which correlations should have been
eliminated.
In another validation, the genotype states of the identified blocs
were plotted for visual inspection, as shown in Figure 3, to ensure
the captured pattern is not misleading. The exceptional diversity
characteristic of this region is apparent in the figure. However,
note in these plots that the psoriatic cases have a smaller
percentage of individuals that are mostly homozygous for the
protective alleles (predominantly dark blue rows in Figure 3) and a
substantially larger percentage of individuals that are mostly
homozygous for the risk alleles (predominantly red rows).
BlocBuster compares the frequencies of each bloc between cases
and controls, so it was necessary to correct for multiple testing. We
employed two approaches for this task, Bonferroni correction and
permutations of phenotypic labels, and observed that the
theoretical and empirical approaches yielded similar thresholds
for this study.
Finally, the association of the bloc was confirmed in an
independent dataset of 439 psoriatic cases and 728 controls with
even higher significances than the original dataset. Replication in
independent data addresses another concern in GWAS: popula-

tion stratification. Population stratification arises when a subset of
individuals in the sample share some common ancestry and are
overrepresented in either the cases or controls. In these scenarios,
alleles associated with their ancestry might appear to be associated
with the phenotype. In order to avoid this issue, samples are
commonly chosen with as much population homogeneity as
possible. Note that bootstrapping trials may be useful to flag
potential stratification as they empirically quantify the sensitivity of
the results to the selections of the samples. High variability of the
test statistic over bootstrapping trials might represent population
stratification. More formally, various statistical methods that utilize
reference panels have been applied to test for stratification.
However, Campbell et al. [72] demonstrated that these measures
might not be adequate and showed that neither structured
associations nor genomic control was able to correct for a false
positive association of the LCT gene with human height. This
association is believed to be false positive as it has not been
validated. In general, testing on independent data is valuable for
addressing the possibility of population stratification within
GWAS. In this study, bootstrapping trials yield a tight confidence
interval. Furthermore, replication in independent data provides an
even stronger association than what was found using the original
data. Taken together, it is not likely that population stratification
inflated the association of ps_1 with psoriasis. These results
indicate this is a bona fide genetic pattern that is strongly
associated with psoriasis.
BlocBuster is fundamentally different from standard network
approaches in several ways. First, it introduces an extension of the
CCC metric [73]. CCC is unique in that it computes a multifaceted collection of correlation values, thereby accommodating
heterogeneity. This accommodation is continued through network
construction by expanding the network scaffolding. Note that in

Figure 5. Map of the ps_1 bloc on chromosome 6. Genes are represented by: (A) C6orf15, (B) PSORS1C1, (C) CDSN, (D) PSORS1C2, (E) CCHCR1, (F)
TCF19, (G) POU5F1, (H) PSORS1C3, (I) HCG27, (J) HLA_C, (K) USP8P1, (L) RPL3P2, and (M) WASF5P. Two SNPs are within known genes: rs3130573 in
PSORS1C1 and PSORS1C2, and rs1265078 in CCHCR1. Shown are chromosomal positions (in Mb) according to Genome Build 37.3, as given by NCBI’s
dbSNP website (http://www.ncbi.nlm.nih.gov/projects/SNP/).
doi:10.1371/journal.pcbi.1003766.g005
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can be useful for association studies in which each SNP is
considered individually, errors introduced are biased toward
inflated LD, which is a property captured by correlation measures.
Consequently, the previous CCC implementation required
elimination of all SNPs containing any missing data, which can
lead to a significant loss of information. An advantage of requiring
complete data is that there are only three possible states for each
biallelic SNP genotype and the previous implementation leveraged
this property with an encoding and table look-up method that
increased computational efficiency. This approach is not practical
for more than three states, thereby occluding extension to
accommodate missing data or multi-allelic data. In view of these
limitations, the CCC algorithm introduced for BlocBuster is an
entirely different approach and employs a simple tallying method
that is similar to Plink’s Fast Epistasis implementation [31]. This
substitution has yielded some loss of computational speed.
However, BlocBuster’s CCC is still three times faster than
Pearson’s correlation coefficient (PCC) and retention of SNPs
with small percentages of missing values is a valuable property.
Furthermore, BlocBuster can be readily extended to analyze multiallelic data. It should be noted that missing data may yield
unexpected results when combinations of SNPs are analyzed and
BlocBuster incorporates several mechanisms to flag any potential
issues (see Methods). A second key difference is that the previous
CCC implementation built two separate networks for cases and
controls and correlations were computed for each group
separately. This strategy can facilitate identification of subtle
patterns. However, spurious correlations arising in one group’s
data might not appear in the other group, subsequently
confounding tests of statistical significance of case/control
associations. Third, the previous CCC approach did not include
any type of validation methods. While replication using independent datasets is ideal, suitable data are often expensive to obtain.
This situation is especially problematic for endophenotypes, such
as gene and protein expression, in which it is unlikely that another
lab would have produced such data independently. It can also be
an issue for well-studied phenotypes due to population-level
variations across independent studies. BlocBuster provides a series
of validation trials for efficient yet rigorous screening of results,
thereby weeding out weak associations prior to further investments. In addition to these key differences, BlocBuster is a fully
developed software package and the C++ source code is freely
available. Using this package we have identified a novel
combinatorial genetic pattern that is significantly associated with
psoriasis, improving upon previous results by providing a genetic
fingerprint of 17 SNP alleles that supplies specific information
along a 211 kb span in the MHC region. This pattern was
extensively computationally validated and confirmed in independent data.
Two caveats of our approach should be noted. First, BlocBuster
is not designed to identify a marker that is independent in its
association with a phenotype. There must be at least two
correlated markers with a combination that exhibits association
for recognition by this approach. For this reason, studies should
employ standard single-marker association tests in addition to
BlocBuster. Second, BlocBuster is diligent in removing false
positives and consequently may miss true signals. However, this
quality ensures the usefulness of the identified blocs for assessing
risk and exploring pathogenesis.
GWAS are prevalent for phenotypes of scientific interest and
future advances hinge on embracing the complexities of combinatorial interactions. Previous approaches for identifying combinatorial patterns presented biases as they relied upon known
information and previous correlation measures were weakened by

general, the degree of heterogeneity and the number of identified
interacting markers can oppose each other during searches for
associations. As the number of identified markers is increased, the
pattern becomes increasingly refined. On one hand, this specificity
has more power to pinpoint individuals bearing an epistatic
pattern that contributes to the phenotype. On the other hand, if
this pattern partially overlaps with another associated epistatic
pattern, inclusion of markers that are not common to both
patterns can weaken associations with the phenotype. For this
reason, heterogeneity should be integrally accommodated
throughout the analysis, as is done by BlocBuster.
Second, the networks created by other methods typically are
comprised of a single connected component that must be
partitioned using some type of clustering strategy. It is not clear
which clustering strategy is the most appropriate and selections of
parameters, e.g. numbers of clusters, can introduce bias and/or
error. In contrast, BlocBuster networks are comprised of discrete
components that are not connected to one another, so there is no
ambiguity about how to separate them. Third, traditional
approaches do not provide specific information regarding the
genetic patterns that have variations between populations, while
BlocBuster explicitly defines these allelic patterns as well as the
relevant statistics. Finally, many other methods rely upon matrices
comprised of similarities between pairs of individuals while
BlocBuster is based upon correlations between SNP alleles, not
individuals. On a related note, BlocBuster supplies a different type
of information than the LD structure captured by tools such as
Haploview [74], as it captures correlations that have potential to
span any genomic distance while omitting uncorrelated markers,
and it supplies the specific alleles that are correlated, not just the
SNPs.
When compared with Pearson’s correlation coefficient (PCC),
CCC identified more than twice as many correlations for the 17
SNPs in ps_1 and PCC split this bloc into pieces. More generally,
PCC was more likely to introduce type I errors, and the PCC
network had lower community structure than the corresponding
CCC network, with the edges more dispersed throughout the
network. As a practical consideration, PCC required three times as
much computation time.
BlocBuster is a computationally efficient approach for GWAS.
In general, direct identification of combinations of three or more
inter-correlated markers is infeasible for GWAS due to the
extremely large number of combinations. Given a pairwise
correlation metric that can be quickly computed, network methods
are efficient alternatives as they compute all pairwise correlations
and build a network with potential to render higher-ordered intercorrelations. CCC is a straight-forward and simple metric and
computations for the dataset of 1,610 individuals and 443,020
SNPs required a total of about 54 days. We ran the analysis on a
cluster of 45 processors, which produced the results in less than a
day and a half. At this rate, scaling up to 3,000,000 SNPs would
require approximately 490 days of computation on a single CPU,
which can be performed in parallel in a reasonable amount of
time, given adequate resources (e.g. about five days on a cluster of
100 processors). Extraction of the blocs from the network using a
breadth-first search and evaluating the associations of these blocs
required only four minutes of computation time on a single
processor.
BlocBuster expands upon the previous CCC implementation
[73] in several key ways. First, the previous approach was unable
to accommodate missing data. Note that imputation of missing
data prior to computing correlations can generate false positive
signals. Such imputations are based upon the assumption of LD
between missing and identified markers [75]. While imputation
PLOS Computational Biology | www.ploscompbiol.org
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warnings are printed out whenever a pair of SNPs possesses more
than a user-defined percentage of individuals with missing data.
Furthermore, each bloc identified as exhibiting a significant
association (see Statistical Analyses below) has the actual sample
sizes utilized in the analysis printed out. Finally, all individuals are
included in the visual inspection of the bloc (to be described
shortly), with the missing genotypes represented by white cells.
These mechanisms ensure that each pattern is correctly represented without imposing risks of imputation errors contributing to
misleading associations.
Network construction. Standard SNP networks consist of n
nodes, where n is equal to the number of SNPs. Consequently, the
allele states that exhibit correlations are lost in the network
abstraction (Figure 6). To overcome this loss of information, each
BlocBuster network is constructed with 2n nodes and each SNP is
represented by two nodes, one for each of its alleles (the current
implementation assumes biallelic SNPs). This strategy supplies the
actual alleles contributing to a pattern, not just the SNPs, and
enables allele-specific testing of patterns. It may also reduce
erroneous merging of distinct patterns into a single bloc, as shown
in Figure 6.
CCC is computed for each pair of SNPs, providing a vector of
four values for each computation, with each value representing
each of the possible SNP allele combinations, as described above.
Then the n highest CCC values are represented by edges in the
network. Note that it is possible for one pair of SNPs to have more
than one edge in the network and it is not uncommon to observe a
high correlation between an allele pair as well as mirrored
correlation between their alternate alleles. On the other hand,
mirrored correlations may not exist, as demonstrated in Figure 1.
The two nodes representing the SNP alleles for each high
correlation are connected with an edge. The resultant network is
comprised of 2n nodes and n edges, representing the n highest
CCC values over all pairs of SNPs, resulting with an average node
degree of one. If the edges were uniformly distributed, the network
would consist of 443,020 doubletons, each of which was comprised
of a single edge connecting two nodes; with every node connected
to precisely one other node in the network. The choice of this
number of edges is somewhat arbitrary, but any smaller number of
edges would make it impossible for every node in the network to
be connected to at least one other node, and a larger number of
edges would result with a less stringent CCC threshold. The
second set of permutation trials indicated that the network density
could be substantially increased with low risk of introducing falsepositive edges, so the number of edges could be increased.
However, increasing the number of edges yields non-decreasing
bloc size and non-increasing frequencies of the bloc pattern. In
essence, the use of a stringent CCC threshold captures only the
strongest of correlations, thereby facilitating the discovery of strong
genetic patterns within the data.
Bloc extraction. We have observed that BlocBuster networks
built from biological data consist of large numbers of singleton
nodes (with no edges) and discrete blocs of nodes with relatively
high densities of edges. Consequently, no clustering methods or
other types of partitioning are required to separate the network. It
is straight-forward to deterministically extract the blocs with a
breadth-first search of the network. The SNP allele pattern that
corresponds to each bloc is then tested for associations between
two sets of individuals, with those that exhibit significant
associations being reported to the user.
Software. Our open source software is freely available at
www.blocbuster.org or by contacting the first author. The code
was written in C++ and implemented and tested on a LINUX
platform.

heterogeneity. BlocBuster’s multi-faceted approach and allelespecific network efficiently accommodate heterogeneity. The
benefits of this accommodation are highlighted by the comparisons
with Pearson’s correlation coefficient, which clearly demonstrate
higher accuracy and reduced type I errors for our approach.
Looking forward, BlocBuster’s efficient selection of correlated
markers will further increase the value of this approach as genetic
data become increasingly affordable and dense.

Materials and Methods
Psoriasis datasets
The genotyping of samples was provided through the Genetic
Association Information Network (GAIN). The datasets used for
the analyses described in this manuscript were obtained from the
GAIN Database at http://view.ncbi.nlm.nih.gov/dbgapcontrolled through dbGaP accession number phs000019.v1.p1.c1,
General Research Use (GRU) and Autoimmune Disease Only
(ADO). Perlegen 500K chips were utilized for both studies.
The GRU dataset included 451,724 SNPs for 1,683 individuals.
The removal of mitochondrial DNA and the X and Y
chromosome SNPs resulted with 443,020 autosomal SNPs. We
removed the children as well as the individuals that did not pass
quality control (defined by the original study). We checked this
extracted data for percentages of missing values and found that
each of the 1,610 individuals and each of the 443,020 SNPs had
no more than 10% missing data. In total, 929 and 681 of these
individuals were labeled as psoriatic cases and normal controls,
respectively.
The ADO data consisted of 451,724 genotypes for each of 1,214
individuals. We removed the individuals that did not pass
previously defined QC, leaving 1,167 individuals. We removed
SNPs from the mitochondrial DNA and X and Y chromosomes,
leaving 443,020 SNPs. Three of these SNPs possessed between
10% and 20% missing data and the rest had less than 10% missing
values. None of the 1,167 individuals had more than 10% missing
data. The final dataset included 439 cases and 728 controls.

BlocBuster
CCC. Our open-source code is available at www.blocbuster.
org or by contacting the first author. BlocBuster is a network
model that employs a custom correlation coefficient (CCC) [73].
High efficiency is achieved by computing a simple calculation that
returns a vector of four values for each SNP pair. Briefly, let A and
a represent the two alleles at the first SNP, and B and b represent
the two alleles at the second SNP. There are four allelic
combinations defined by these two SNPs: AB, Ab, aB, and ab.
Each of these four combinations is evaluated independently of
each other, providing a vector of four values that are utilized for
network construction as described below.
Note that missing data should not be imputed prior to
computing correlations as imputation errors are biased toward
inflated LD. On the other hand, the retention of SNPs with
missing data can yield unexpected consequences when combinations of SNPs are analyzed. For example, two SNPs with 20%
missing data could results with up to 40% of the individuals
missing one genotype value, and these individuals should not be
included in an assessment of correlation between the two SNPs.
Furthermore, when assessing associations for a combination of
SNP alleles, the inclusion of individuals with excessive missing data
for the combination can yield misleading results. BlocBuster
employs several mechanisms to flag potential issues that might
arise. BlocBuster omits individuals with missing genotypes for
either of the SNPs in the given pair when computing CCC and
PLOS Computational Biology | www.ploscompbiol.org
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p(1-q)/q(1-p), where p and q equal the frequencies of the bloc for cases
and controls, respectively.) The 95% confidence interval is defined as
e ‘ [ln(OR)+/21.96 sqrt(1/a+1/b+1/c+1/d)], where ln(OR) equals
the natural log of ad/bc and sqrt is the square root.
G-test is a maximum likelihood statistical significance test
which converges to the chi-squared distribution more accurately than Pearson’s chi-squared test [76]. The p-value of
significance corresponding to the G-test score, with Bonferroni
correction for multiple testing, was used for evaluating each
bloc. We used the following formula for the G-test of
independence:

Statistical Analyses
An underlying entailment of most
existing network approaches is that correlations are transitive. For
example, when grouping markers into clusters, where for three
markers, A, B and C, in one cluster, if A is correlated with B and B is
correlated with C, then A is implied to be correlated with C.
However, this hidden assumption might not be valid, or even
problematic, as different subsets of individuals may be contributing to
each of the correlations. Consider the case where individuals bearing
both A and B or bearing both B and C are at high risk for the disease,
but individuals with only A and C are not at increased risk. Such a
case would violate transitivity. For this reason, BlocBuster tests each
of these patterns by tallying the frequencies of the bloc in its entirety.
Furthermore, because we are interested in identifying associations
with complex phenotypes, we compare the frequencies between
phenotypic groups. Such tests are not straightforward for existing
network approaches as current correlation metrics only indicate
which pairs of SNPs are correlated and do not supply which alleles of
the SNP pairs contribute to the correlations.
Since the networks were blindly built using a combination of
the data for all of the individuals, it could be expected that most
blocs are common at the population level, with no association to
the phenotype. However, because CCC accommodates genetic
heterogeneity, it might also be expected that some of these blocs
exhibit significant association with the phenotype status, which is
one type of heterogeneity. Three metrics were used to evaluate
the significance of these patterns: odds ratio, Bonferronicorrected p-value based on the G-test of independence, and
corrected p-value based on permutation trials. These metrics
were computed for all blocs that were possessed by at least ten
individuals in the entire sample. Individuals that have more than
5% missing genotype values for the SNPs in a given bloc were not
included in the computations. However, these individuals were
included in the plots of genotype values for visual inspections, as
described below.
The odds ratio was computed as OR = ad/bc, where a and b equal
the numbers of the bloc of interest possessed by the cases and controls,
respectively. Each individual possesses two allelic combinations that
include the SNPs in the bloc. The sum of the combinations that are
not identical to the given bloc is represented by c for the cases and by
d for the controls. (Stated in another way, the odds ratio is equal to
G-test and odds ratio.

G~2

Oi :ln(Oi =Ei )

i

where Oi and Ei equal the observed and expected number of
entire bloc patterns in subset i. The expected numbers of blocs
were computed using the observed numbers of blocs as a 262
table, where the null hypothesis is that the relative proportions
of each variable are independent of each other. The summation
is over four subsets (corresponding to the four cells of the 262
table), and ‘ln’ denotes the natural logarithm.
Permutation trials for multiple testing corrections. In
addition to using Bonferroni correction, an empirical approach
via permutation trials was employed. We permuted the
phenotype labels across the samples, tallied the numbers of
carriers of each bloc for each of these randomized groups of
individuals, and computed the G-test scores. There were 1,000
permutations and all 54,425 blocs in the original network were
tested for each permutation. For each permutation, the
individuals were randomly assigned into groups of 929 and
681 individuals and the bloc frequencies in these two groups
were compared.

Validation
In order to ensure the robustness of our results, we employed a
series of validation trials, as follows.
Permutation trials for assessing type I errors. Permutation
trials were utilized to test whether significant correlations might
have arisen in the data by random chance. In these trials the
genotypes of the individuals were randomly shuffled for each
SNP. Consequently, each SNP had its original allele and
genotype frequencies; the only change was that the inherent
‘‘correlations’’ between pairs of SNPs had been removed by
randomly rearranging the genotypes across individuals. After
each randomization, the CCC values for every pair of SNPs were
computed. These trials indicated the likelihood that type I errors
arose during computations of correlations; such errors would
create false-positive edges in the network.
Variation of network density. To test the robustness of
the blocs to variation of network density, we built a series of
networks with n edges representing the n highest CCC values.
We varied n from 50,000 to 500,000 edges, at 50,000
increments, and tracked the bloc of interest through these
varying densities.
Bootstrapping trials. Bootstrapping trials were employed in
which we randomly selected half of the cases and half of the
controls and computed the odds ratios and p-values for the bloc of
interest. These randomized trials were repeated 1,000 times, with
the odds ratio and p-value recorded for each trial. The means and
the 95% confidence intervals over the 1,000 trials for each of these
statistics were computed.
Visual inspection. The genotype values for the significant
bloc were plotted for the psoriatic cases and controls for visual

Figure 6. Comparison of SNP network construction methods.
The network in (a) represents each SNP by a single node, as is done by
previous approaches, and the network in (b) employs a node for each of
the SNP alleles. Allele ‘A’ for SNP 1 is correlated with allele ‘b’ of SNP 2,
and allele ‘B’ of SNP 2 is correlated with allele ‘C’ of SNP 3. Allelic
information is lost in a standard network (a), resulting with an incorrect
linking of allele 1A with 3C. The BlocBuster approach also enables allelespecific testing of bloc patterns.
doi:10.1371/journal.pcbi.1003766.g006
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inspection. We utilized our previously developed rearrangement
clustering method, TSP+k [77], to reorder the individuals (rows)
and place similar individuals near each other. Briefly, the genotype
values for the SNPs for each bloc were extracted from the data and
converted to an instance of the Traveling Salesman Problem (TSP)
[78] in which each individual was represented as a city. We
inserted three dummy cities to facilitate three clusters and solved
the optimal ordering of the cities using NEOS’s [79] Concorde
solver (www.tsp.gatech.edu/concorde.html). The individuals were
reordered using this solution. Using this ordering of individuals,
the genotypes were color-encoded with dark blue, light blue, red,
and white representing homozygote for the protective allele,
heterozygote, homozygote for the risk allele, and missing data,
respectively. The matrices of genotypic values were plotted for the
cases and controls, as shown in Figure 3.
Replication in independent data. We tested the identified
psoriasis bloc for phenotypic association in an independent data set,
the Genetic Association Information Network (GAIN) Autoimmune
Disease Only (ADO) data. These data are described at the beginning
of this section.
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